How Genomics Is Personalizing Drug Discovery
October 20, 2026
Regeneron Genetics Center’s Luca Lotta explains how population-scale genetic evidence can reveal more promising drug targets and open new possibilities for disease prevention
4 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
Bruce Levine
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine
View ProfileMusings from The Power List: Claudia Zylberberg
Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale
Latest News
All the latest Medicine Maker articles.
SRSF1 Gene Delivery Extends Lifespan in Aged Mice
October 19, 2026
An RNA sequencing and machine learning screening platform identified an RNA-processing factor that reduced markers of cellular aging without erasing cell identity
2 min read
Three Targets, One CAR T Therapy
October 19, 2026
First-in-human study demonstrates the potential of rapidly manufactured trispecific CAR T cells to deliver durable remissions in B-cell lymphoma
3 min read
Hiring for What Comes Next
October 19, 2026
Biotech boards are looking beyond big names to find leaders with the experience and flexibility to handle the company’s next major challenge.
6 min read
Video: Building the Airplane While Flying It – with Jonny Wray
October 16, 2026
Nucleome Therapeutics CTO Jonny Wray reveals how an engineer’s mindset can help navigate the complexity of human biology
1 min read
Looking Beyond Symptoms in Psychiatric Drug Development
October 15, 2026
Advances in translational science are helping researchers better understand psychiatric disease biology, says Tanya Wallace
8 min read
CRISPR Cuts Cholesterol for a Year
October 14, 2026
A single CRISPR infusion sustained reductions in LDL cholesterol and triglycerides for 12 months.
2 min read
Musings From the Power List: Jason Bock
October 14, 2026
Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development
12 min read
Bringing CAR T Closer to Home
October 13, 2026
CAR T Vision aims to widen access to cell therapy by expanding community-based delivery, easing operational barriers, and building sustainable funding models
7 min read
CRISPR-Based Delivery System Generates CAR T Cells In Vivo
October 13, 2026
A two-vector delivery system generates tumor-targeting CAR T cells directly inside the body, achieving complete responses in mouse cancer models
3 min read
Caribou Halts Allogeneic CAR T Programs as Funding Pressures Mount
October 12, 2026
“Caribou’s story has taken a heartbreaking turn,” says CEO Rachel Haurwitz, with the CRISPR-focused biotech set to discontinue vispa-cel and CB-011, and reduce its workforce
2 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.